PCDH1, a poor prognostic biomarker and potential target for pancreatic adenocarcinoma metastatic therapy
Số trang: 17
Loại file: pdf
Dung lượng: 7.92 MB
Lượt xem: 14
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
d Pancreatic adenocarcinoma (PAAD) is an aggressive solid tumour characterised by few early symptoms, high mortality, and lack of effective treatment. Therefore, it is important to identify new potential therapeutic targets and prognostic biomarkers of PAAD.
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Pancreatic adenocarcinoma Prognostic biomarker Protocadherin 1 Pirinixic acid Therapeutic targetGợi ý tài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 171 0 0 -
6 trang 166 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 142 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 119 0 0 -
12 trang 93 0 0
-
19 trang 74 0 0
-
17 trang 64 0 0
-
9 trang 43 0 0
-
12 trang 38 0 0
-
Investigating the prognostic and predictive value of the type II cystatin genes in gastric cancer
17 trang 37 0 0 -
13 trang 37 0 0
-
11 trang 37 0 0
-
Tracking tumor alteration in glioma through serum fibroblast activation protein combined with image
10 trang 35 0 0 -
Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia
9 trang 35 0 0 -
11 trang 34 0 0
-
9 trang 33 0 0
-
CYP4B1 polymorphisms and the risk of breast cancer in Chinese women: A case-control study
14 trang 32 0 0 -
11 trang 32 0 0
-
16 trang 32 0 0
-
22 trang 32 0 0